|
|
|
|
LEADER |
00000cam a22000002 4500 |
001 |
1609000471 |
003 |
DE-627 |
005 |
20230428165419.0 |
007 |
tu |
008 |
000229s1998 xx ||||| t 00| ||eng c |
020 |
|
|
|a 9282829138
|9 92-828-2913-8
|
035 |
|
|
|a (DE-627)1609000471
|
035 |
|
|
|a (DE-576)083628274
|
035 |
|
|
|a (DE-599)BSZ083628274
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
088 |
|
|
|a EUR 18153 EN
|
245 |
1 |
0 |
|a COST A6 - Evaluation research in regard to primary prevention of drug abuse
|c European Commission, Directorate-General Science, Research and Development. Ed. by Alfred Springer ...
|
246 |
3 |
3 |
|a Evaluation research in regard to primary prevention of drug abuse
|
264 |
|
1 |
|a Luxembourg
|b Office for Official Publ. of the European Communities
|c 1998
|
300 |
|
|
|a 235 S.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
655 |
|
7 |
|a Forschungsbericht
|0 (DE-588)4155043-2
|0 (DE-627)10467444X
|0 (DE-576)209815833
|2 gnd-content
|
700 |
1 |
|
|a Springer, Alfred
|e Hrsg.
|4 edt
|
710 |
2 |
|
|a Europäische Kommission
|b Generaldirektion Wissenschaft, Forschung und Entwicklung
|0 (DE-588)5118595-7
|0 (DE-627)172347955
|0 (DE-576)195031431
|4 oth
|
856 |
4 |
2 |
|u http://media.obvsg.at/AC02417372-1002
|q text/html
|x Verlag
|3 Inhaltsverzeichnis
|
935 |
|
|
|a mkri
|
951 |
|
|
|a BO
|
ELC |
|
|
|b 1
|
LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
LOK |
|
|
|0 001 3141261350
|
LOK |
|
|
|0 003 DE-627
|
LOK |
|
|
|0 004 1609000471
|
LOK |
|
|
|0 005 20040209000000
|
LOK |
|
|
|0 008 000229||||||||||||||||ger|||||||
|
LOK |
|
|
|0 040
|a DE-Frei85
|c DE-627
|d DE-Frei85
|
LOK |
|
|
|0 852
|a DE-Frei85
|
LOK |
|
|
|0 852 1
|m p
|9 00
|
LOK |
|
|
|0 938
|k p
|
ORI |
|
|
|a SA-MARC-krimdoka001.raw
|